Latest Period
Q1 2026
Security Snapshot
Strata Critical Medical, Inc. - Common Stock (SRTA) Institutional Ownership
CUSIP: 092667104
13F Institutional Holders and Ownership History from Q1 2019 to Q1 2026
Institutions Reporting
126
Shares (Excl. Options)
55,803,558
Price
$4.18
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- SRTA on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 55,803,558
- Total 13F value
- $233,248,646
- Portfolio coverage rank
- 0%
- Share change
- +3,695,424
- Value change
- +$14,870,587
- Number of holders
- 126
- Shares outstanding
- 86,992,812
- SEC-reported price per share
- $5.47
- Insider filing price
- $5.47
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SRTA - Strata Critical Medical, Inc. - Common Stock is tracked under CUSIP 092667104.
- 126 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 126 to 126 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $250,146,841 to $233,248,646.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 126 institutions filings for Q1 2026.
Security key
092667104
Latest holder period
Q1 2026
13F holders
126
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
SRTA full holder history
Strata Critical Medical, Inc. SEC filings
Strata Critical Medical, Inc. company facts
Strata Critical Medical, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 092667104:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
SRTA
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARK Investment Management LLC | 8.6% | +13% | $36,679,997 | +$5,169,439 | 7,455,284 | +16% | ARK Investment Management LLC | 31 Mar 2026 |
| Third Point LLC | 5.8% | -5% | $25,300,000 | 5,000,000 | 0% | Third Point LLC | 30 Sep 2025 | |
| BlackRock, Inc. | 5.1% | +2.8% | $21,091,147 | +$760,084 | 4,384,945 | +3.7% | BlackRock, Inc. | 31 Dec 2025 |
As of 31 Mar 2026, 126 institutional investors reported holding 55,803,558 shares of Strata Critical Medical, Inc. - Common Stock (SRTA). This represents 64% of the company’s total 86,992,812 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
58%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARK Investment Management LLC | 8.6% | 7,455,284 | +4.8% | 0.24% | $31,163,087 |
| Third Point LLC | 5.7% | 5,000,000 | 0% | 1% | $20,900,000 |
| BlackRock, Inc. | 5.3% | 4,568,268 | +1.7% | 0% | $19,095,360 |
| Northern Right Capital Management, L.P. | 4.7% | 4,090,169 | +43% | 6.1% | $17,096,906 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.3% | 2,872,446 | 0% | 0% | $12,006,824 |
| AWM Investment Company, Inc. | 3.2% | 2,821,468 | 0% | 1.3% | $11,793,736 |
| ROYCE & ASSOCIATES LP | 3.2% | 2,816,372 | +61% | 0.12% | $11,772,435 |
| Pillsbury Lake Capital LLC | 3% | 2,603,796 | +32% | 4.9% | $10,883,867 |
| First Eagle Investment Management, LLC | 2.6% | 2,266,243 | +6.4% | 0.02% | $9,472,895 |
| GEODE CAPITAL MANAGEMENT, LLC | 2% | 1,699,710 | +2.7% | 0% | $7,107,250 |
| Sumitomo Mitsui Trust Group, Inc. | 1.9% | 1,654,361 | -1.4% | 0% | $6,915,229 |
| Amova Asset Management Americas, Inc. | 1.9% | 1,654,361 | -1.4% | 0.1% | $6,898,685 |
| DIMENSIONAL FUND ADVISORS LP | 1.9% | 1,617,104 | +12% | 0% | $6,758,577 |
| STATE STREET CORP | 1.5% | 1,346,075 | +1.1% | 0% | $5,626,594 |
| Uniplan Investment Counsel, Inc. | 1.5% | 1,300,317 | +2.9% | 0.56% | $5,435,325 |
| Bank of New York Mellon Corp | 1.2% | 1,079,025 | -3.5% | 0% | $4,510,326 |
| Creek Drive Management Group LLC | 1.2% | 1,060,000 | +74% | 2.8% | $4,430,800 |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 0.82% | 712,524 | -6.6% | 0.23% | $2,978,350 |
| NORTHERN TRUST CORP | 0.74% | 643,635 | +33% | 0% | $2,690,394 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 0.62% | 539,510 | -8.9% | 0.17% | $2,255,152 |
| MORGAN STANLEY | 0.57% | 497,858 | -35% | 0% | $2,081,047 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 0.56% | 483,420 | 0% | 0% | $2,020,696 |
| RENAISSANCE TECHNOLOGIES LLC | 0.55% | 474,886 | -21% | 0% | $1,985,023 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.52% | 453,882 | +30% | 0.04% | $1,897,227 |
| VANGUARD FIDUCIARY TRUST CO | 0.5% | 432,269 | 0% | 0% | $1,806,884 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
29
Latest
Q1 2026
Rows shown
1-25 of 29
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 55,803,558 | $233,248,646 | +$14,870,587 | $4.18 | 126 |
| 2025 Q4 | 52,008,878 | $250,146,841 | +$9,910,903 | $4.81 | 126 |
| 2025 Q3 | 47,286,362 | $239,206,127 | +$14,930,619 | $5.06 | 136 |
| 2025 Q2 | 44,455,005 | $179,183,574 | +$8,630,071 | $4.03 | 124 |
| 2025 Q1 | 42,573,092 | $116,252,652 | -$2,666,480 | $2.73 | 117 |
| 2024 Q4 | 43,353,242 | $184,230,440 | +$11,523,087 | $4.25 | 119 |
| 2024 Q3 | 41,177,565 | $121,252,962 | +$5,683,512 | $2.94 | 119 |
| 2024 Q2 | 38,807,858 | $134,994,588 | +$4,500,006 | $3.48 | 115 |
| 2024 Q1 | 37,468,293 | $106,750,264 | +$6,028,180 | $2.85 | 112 |
| 2023 Q4 | 35,332,178 | $124,791,578 | +$3,955,619 | $3.53 | 98 |
| 2023 Q3 | 34,343,140 | $88,930,371 | -$7,931,136 | $2.59 | 101 |
| 2023 Q2 | 36,346,707 | $143,117,927 | -$1,612,269 | $3.94 | 91 |
| 2023 Q1 | 37,275,583 | $125,607,577 | -$6,294,513 | $3.38 | 88 |
| 2022 Q4 | 39,093,511 | $139,905,215 | +$648,352 | $3.58 | 91 |
| 2022 Q3 | 38,748,710 | $156,009,485 | -$2,349,790 | $4.03 | 90 |
| 2022 Q2 | 39,320,621 | $193,883,296 | +$22,393,418 | $4.46 | 86 |
| 2022 Q1 | 32,701,085 | $275,248,499 | -$27,554,097 | $8.49 | 70 |
| 2021 Q4 | 35,699,144 | $315,671,183 | +$72,718,787 | $8.83 | 77 |
| 2021 Q3 | 27,281,482 | $284,480,728 | +$37,270,022 | $10.40 | 77 |
| 2021 Q2 | 23,713,890 | $249,189,810 | +$249,182,810 | $10.50 | 74 |
| 2021 Q1 | 700 | $7,000 | $10.14 | 1 | |
| 2020 Q4 | 700 | $7,000 | $10.00 | 1 | |
| 2020 Q3 | 700 | $7,000 | $10.00 | 1 | |
| 2020 Q2 | 700 | $7,000 | $10.00 | 1 | |
| 2020 Q1 | 700 | $7,000 | $10.00 | 1 |